Weekly oral alendronate in mevalonate kinase deficiency

BACKGROUND: Mevalonate kinase deficiency (MKD) is caused by mutations in the MVK gene, encoding the second enzyme of mevalonate pathway, which results in subsequent shortage of downstream compounds, and starts in childhood with febrile attacks, skin, joint, and gastrointestinal symptoms, sometimes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantarini, Luca, Vitale, Antonio, Magnotti, Flora, Lucherini, Orso Maria, Caso, Francesco, Frediani, Bruno, Galeazzi, Mauro, Rigante, Donato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880037/
https://www.ncbi.nlm.nih.gov/pubmed/24360083
http://dx.doi.org/10.1186/1750-1172-8-196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880037/
https://www.ncbi.nlm.nih.gov/pubmed/24360083
http://dx.doi.org/10.1186/1750-1172-8-196

Ejemplares similares